Skip to content
10-Q

Quarterly Report

AVIDITY BIOSCIENCES, INC.

0001599901-25-000210

← back to feed
Filed
Nov 10, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 150.68M sh
Shares Diluted Q3 2025 · Sep 30, 2025 137.9M sh
Shares Diluted Q3 2025 · Sep 30, 2025 132.28M sh
Shares Diluted Q3 2025 · Sep 30, 2024 123.38M sh
Shares Diluted Q3 2025 · Sep 30, 2024 105.9M sh
Capex Q3 2025 · Sep 30, 2025 $7.81M
Capex Q3 2025 · Sep 30, 2024 $3.15M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$480.67M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$201M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $350.16M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $219.87M
Stockholders Equity Q3 2025 · Sep 30, 2025 $1.89B
Stockholders Equity Q3 2025 · Jun 30, 2025 $1.19B
Stockholders Equity Q3 2025 · Mar 31, 2025 $1.33B
Stockholders Equity Q3 2025 · Dec 31, 2024 $1.42B
Stockholders Equity Q3 2025 · Sep 30, 2024 $1.5B
Stockholders Equity Q3 2025 · Jun 30, 2024 $1.22B
Stockholders Equity Q3 2025 · Mar 31, 2024 $830.9M
Stockholders Equity Q3 2025 · Dec 31, 2023 $500.76M
Current Liabilities Q3 2025 · Sep 30, 2025 $169.88M
Current Liabilities Q3 2025 · Dec 31, 2024 $98.02M
Total Liabilities Q3 2025 · Sep 30, 2025 $247.94M
Total Liabilities Q3 2025 · Dec 31, 2024 $138.94M
Current Assets Q3 2025 · Sep 30, 2025 $1.97B
Current Assets Q3 2025 · Dec 31, 2024 $1.54B
Total Assets Q3 2025 · Sep 30, 2025 $2.13B
Total Assets Q3 2025 · Dec 31, 2024 $1.56B
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.27
Eps Diluted Q3 2025 · Sep 30, 2025 −$3.38
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.65
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.08
Eps Basic Q3 2025 · Sep 30, 2025 −$1.27
Eps Basic Q3 2025 · Sep 30, 2025 −$3.38
Eps Basic Q3 2025 · Sep 30, 2024 −$0.65
Eps Basic Q3 2025 · Sep 30, 2024 −$2.08
Sga Expense Q3 2025 · Sep 30, 2025 $46.33M
Sga Expense Q3 2025 · Sep 30, 2025 $116.8M
Sga Expense Q3 2025 · Sep 30, 2024 $23.27M
Sga Expense Q3 2025 · Sep 30, 2024 $57.9M
Rd Expense Q3 2025 · Sep 30, 2025 $154.95M
Rd Expense Q3 2025 · Sep 30, 2025 $392.56M
Rd Expense Q3 2025 · Sep 30, 2024 $77.2M
Rd Expense Q3 2025 · Sep 30, 2024 $207.97M
Net Income Q3 2025 · Sep 30, 2025 −$174.44M
Net Income Q3 2025 · Sep 30, 2025 −$447.53M
Net Income Q3 2025 · Jun 30, 2025 −$157.32M
Net Income Q3 2025 · Mar 31, 2025 −$115.77M
Net Income Q3 2025 · Sep 30, 2024 −$80.4M
Net Income Q3 2025 · Sep 30, 2024 −$220.05M
Net Income Q3 2025 · Jun 30, 2024 −$70.79M
Net Income Q3 2025 · Mar 31, 2024 −$68.86M
Operating Income Q3 2025 · Sep 30, 2025 −$188.81M
Operating Income Q3 2025 · Sep 30, 2025 −$491.47M
Operating Income Q3 2025 · Sep 30, 2024 −$98.13M
Operating Income Q3 2025 · Sep 30, 2024 −$257.95M
Revenue Q3 2025 · Sep 30, 2025 $12.48M
Revenue Q3 2025 · Sep 30, 2025 $17.9M
Revenue Q3 2025 · Sep 30, 2024 $2.34M
Revenue Q3 2025 · Sep 30, 2024 $7.92M